Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Whitehawk Therapeutics Inc (WHWK)

Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,349
  • Shares Outstanding, K 47,128
  • Annual Sales, $ 25,980 K
  • Annual Income, $ -63,690 K
  • EBIT $ -102 M
  • EBITDA $ -103 M
  • 60-Month Beta 0.38
  • Price/Sales 4.64
  • Price/Cash Flow N/A
  • Price/Book 0.77

Options Overview Details

View History
  • Implied Volatility 413.01% (+207.62%)
  • Historical Volatility 75.90%
  • IV Percentile 81%
  • IV Rank 63.94%
  • IV High 618.90% on 09/05/25
  • IV Low 47.99% on 10/23/25
  • Expected Move (DTE 13) 0.51 (20.48%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 16
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,190
  • Open Int (30-Day) 1,419
  • Expected Range 1.98 to 3.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.69
  • Number of Estimates 2
  • High Estimate -0.27
  • Low Estimate -1.11
  • Prior Year -0.67
  • Growth Rate Est. (year over year) -2.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.97 +26.40%
on 11/20/25
2.59 -3.86%
on 12/05/25
+0.24 (+10.67%)
since 11/05/25
3-Month
1.76 +41.48%
on 09/09/25
3.77 -33.95%
on 10/16/25
+0.67 (+36.81%)
since 09/05/25
52-Week
1.39 +79.14%
on 04/25/25
3.81 -34.68%
on 01/08/25
+0.13 (+5.51%)
since 12/05/24

Most Recent Stories

More News
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer

Dr. Dugan brings extensive clinical development leadership to Whitehawk as ADC programs near the clinic

WHWK : 2.49 (-2.73%)
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

MORRISTOWN, N.J. , Nov. 26, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently...

WHWK : 2.49 (-2.73%)
AI-Powered Platforms Scale as Preventive Care and Biomarker Testing Converge

VANCOUVER – Baystreet.ca News Commentary – Healthcare providers are prioritizing preventive care strategies as nearly 58% now integrate biomarker testing into early wellness indicators [1], a shift...

HIMS : 39.20 (-2.05%)
TEM : 76.66 (+0.43%)
WHWK : 2.49 (-2.73%)
BFLY : 3.06 (unch)
ALEN-U.CN : 1.3400 (unch)
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London

MORRISTOWN, N.J. , Nov. 11, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently...

WHWK : 2.49 (-2.73%)
Whitehawk Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

MORRISTOWN, N.J. , Nov. 6, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently...

WHWK : 2.49 (-2.73%)
Funding Is Back in Digital Health, Marking Move into AI Wellness Renaissance

Issued on behalf of Aleen Inc. VANCOUVER – Baystreet.ca News Commentary – So far, the latest Q3 funding surge[1] has shown digital wellness building speed again as investors are backing AI...

CCLD : 3.11 (-0.96%)
TEM : 76.66 (+0.43%)
WHWK : 2.49 (-2.73%)
WAY : 34.35 (-2.97%)
ALEN-U.CN : 1.3400 (unch)
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC

PTK7 is the third most highly expressed tumor marker among clinically validated and emerging ADC targets, present in ~70% of tumors

WHWK : 2.49 (-2.73%)
Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a multi-year collaboration with Whitehawk Therapeutics, Inc. (NASDAQ: WHWK),...

TEM : 76.66 (+0.43%)
WHWK : 2.49 (-2.73%)
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

MORRISTOWN, N.J. , Sept. 2, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology...

WHWK : 2.49 (-2.73%)
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

MORRISTOWN, N.J. , Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology...

WHWK : 2.49 (-2.73%)

Business Summary

Aadi Bioscience Inc. is a clinical-stage biopharmaceutical company. It focuses on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes. Aadi Bioscience Inc., formerly known as Aerpio Pharmaceuticals Inc., is based in LOS ANGELES.

See More

Key Turning Points

3rd Resistance Point 2.66
2nd Resistance Point 2.62
1st Resistance Point 2.56
Last Price 2.49
1st Support Level 2.46
2nd Support Level 2.42
3rd Support Level 2.36

See More

52-Week High 3.81
Fibonacci 61.8% 2.89
Fibonacci 50% 2.60
Last Price 2.49
Fibonacci 38.2% 2.32
52-Week Low 1.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar